Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01208051
Title Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland carcinoma

Therapies

Cediranib + Lenalidomide

Cediranib

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California Davis Comprehensive Cancer Center P2C Sacramento California 95817 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
City of Hope South Pasadena South Pasadena California 91030 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 United States Details
Ingalls Memorial Hospital Harvey Illinois 60426 United States Details
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451 United States Details
Illinois CancerCare-Peoria Peoria Illinois 61615 United States Details
Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne Indiana 46845 United States Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Minnesota Oncology Hematology PA-Minneapolis Minneapolis Minnesota 55407 United States Details
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Mercy Hospital Saint Louis Saint Louis Missouri 63141 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Penn State Children's Hospital Hershey Pennsylvania 17033 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
London Regional Cancer Program London Ontario N6A 4L6 Canada Details
University Health Network-Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field